Multicenter trial exploring calcineurin inhibitors avoidance in renal transplantation. - Wikidata - awgldk - TriplyDB

Multicenter trial exploring calcineurin inhibitors avoidance in renal transplantation.

Multicenter trial exploring calcineurin inhibitors avoidance in renal transplantation.

http://www.wikidata.org/entity/Q43633987

about

Reviewing 15 years of experience with sirolimus Cytochrome P450 2J2: distribution, function, regulation, genetic polymorphisms and clinical significance.Strategies to reduce toxicities and improve outcomes in renal transplant recipients.Mycophenolate mofetil: safety and efficacy in the prophylaxis of acute kidney transplantation rejection.Belatacept : a new biological agent for maintenance immunosuppression in kidney transplantation.New developments in immunosuppressive therapy in renal transplantation.Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipients Avoiding steroids in solid organ transplantation.Cyclosporine: a review.The clinical application of monoclonal antibody therapies in renal transplantation.Daclizumab induction in solid organ transplantation.Maximizing the clinical outcome with mTOR inhibitors in the renal transplant recipient: defining the role of calcineurin inhibitors.Strategies to prevent chronic allograft nephropathy in kidney transplantation: focus on calcineurin inhibitors.Current and future immunosuppressive strategies in renal transplantation.Adverse Outcomes of Tacrolimus Withdrawal in Immune-Quiescent Kidney Transplant Recipients.Interleukin-2 receptor antagonist induction in modern immunosuppression regimens for renal transplant recipients.Mycophenolate mofetil and sirolimus combination in renal transplantation.The role of basiliximab induction therapy in organ transplantation.Long-term efficacy and safety of a calcineurin inhibitor-free regimen in live-donor renal transplant recipients Calcineurin inhibitor-free immunosuppression in kidney transplantation.Daclizumab.Minimizing immunosuppression, an alternative approach to reducing side effects: objectives and interim result.Role of cytochrome P450 2C8 and 2J2 genotypes in calcineurin inhibitor-induced chronic kidney disease.New immunosuppressive agents in pediatric transplantation.Ten years experience with belatacept-based immunosuppression after kidney transplantation.Summary of the US FDA approval of belatacept.Everolimus: preventing organ rejection in adult kidney transplant recipients.An evaluation of sirolimus in renal transplantation.Is it time to give up with calcineurin inhibitors in kidney transplantation?Recollective homeostasis and the immune consequences of peritransplant depletional induction therapy.Induction therapy in renal transplant recipients: a review.Calcineurin inhibitor-sparing regimens based on mycophenolic acid after kidney transplantation.Challenges and opportunities in targeting the CD28/CTLA-4 pathway in transplantation and autoimmunity.A safety evaluation of belatacept for the treatment of kidney transplant.Higher calcineurin inhibitor levels predict better kidney graft survival in patients with de novo donor-specific anti-HLA antibodies: a cohort study.Different in vitro proliferation and cytokine-production inhibition of memory T-cell subsets after calcineurin and mammalian target of rapamycin inhibitors treatment.An update on chemical pharmacotherapy options for the prevention of kidney transplant rejection with a focus on costimulation blockade.Signaling T-cell survival and death by IL-2 and IL-15.Enteric-coated mycophenolate sodium - current and future use in transplant patients.Early Conversion to Prednisolone/Everolimus as an Alternative Weaning Regimen Associates With Beneficial Renal Transplant Histology and Function: The Randomized-Controlled MECANO Trial.

P2860

Q28080955-B045401D-1857-4C2C-981F-304AFBF62A06 Q34358307-8C2018B4-84D2-47A9-94E5-DF4963E04F45 Q34566924-E0E52030-267A-4D24-B770-187D96D9AACD Q34607590-9ED4575E-4F6B-43B4-8E5A-0FC5B83FD1AE Q34638056-5B923FCB-B6ED-4B23-AD93-FCBB8D0C395D Q34701373-DE68D3E0-0DBF-4FA3-AD37-A5F5856F66FE Q34753440-63D9851D-8F60-47FA-BE5B-977599422806 Q35099754-88D023C4-BFD9-4F24-8997-40E7B53EABFA Q35675934-B257E9EF-67F2-43F3-B3FE-1911D3291423 Q35779272-1B2C0AFF-8608-423E-A5CB-103D2F300EB0 Q35779394-C81C96F5-253C-46BC-862A-D8AB697E3DB3 Q35819373-EBC284EF-6ABC-4016-B1FD-E59122AE45E7 Q35841386-9E8CEEB5-B49B-4231-9FA9-7B16A6562E80 Q35906315-FC21B2CC-3954-4802-9E32-A976B420E860 Q36314978-733F73ED-4293-4C2E-926C-4E4B7EB8A628 Q36505748-DF978F7F-927F-4E79-868F-35458FF2C851 Q36575992-6933D4F2-801E-496E-8FF9-B783CEB22A36 Q36675465-ED9FEED7-0F39-470D-A168-13E9AEA43745 Q36677625-EDFD8B95-EF3D-4EFD-AB5C-E881D379223A Q36889001-E236740B-BC28-4371-8A3C-D13D8C57A186 Q36960518-1E57ED24-CF9E-4D14-9942-EA4A0856B9E0 Q37097694-3C88C157-E3A0-4451-AF5C-46187DAD4FE1 Q37259666-B13BCFA1-D030-4F3F-B9D3-40E430EFC9CC Q37446883-8B643048-9DDE-422B-AEA9-7F263F78CF0D Q37604599-21EA42A2-9BD6-4137-A7B5-F90485915F43 Q37984076-95A5EE3D-F210-4451-AA47-F45B04A5C025 Q37992135-7E51E666-96DE-4305-B75B-972EA05DF33A Q38038696-06A42E49-373C-45D6-92BB-B96C952E7668 Q38156847-EC1A5A2E-E334-4FBA-80E9-2F88A6B087B2 Q38187176-7F6F8E55-83DE-4CD6-B4E5-E0CFCB63F2D5 Q38258154-59DABB49-CEF6-46D9-99FD-C9F668AC5174 Q38307029-452AF8BC-D18B-48C7-B66E-F6E3CFE7AC2A Q38681685-C29CE347-60B1-4636-BF6B-A1DB2426683D Q38852360-04CA76CD-9125-46A9-8CD6-305447A676C9 Q38967641-88E8A175-C056-41D6-A384-EFE2275B3F48 Q39956641-263C6D07-69E6-4F5D-96B1-D1B0B6A1F1CA Q40220124-F56D7BAC-ED67-4C61-8D6F-9F065A2B1570 Q40364306-0C308B5C-CEBE-4200-9418-64DEC85FD96B Q40409829-31ED9CC9-273F-4316-A90A-F8D6EC6FEF4C Q40505344-8B624F86-AB42-412E-9C08-C77B95FDFCCE

P2860

Multicenter trial exploring calcineurin inhibitors avoidance in renal transplantation.

http://www.wikidata.org/entity/Q43633987

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh-hant

name

Multicenter trial exploring calcineurin inhibitors avoidance in renal transplantation.

@en

Multicenter trial exploring calcineurin inhibitors avoidance in renal transplantation.

@nl

type

label

Multicenter trial exploring calcineurin inhibitors avoidance in renal transplantation.

@en

Multicenter trial exploring calcineurin inhibitors avoidance in renal transplantation.

@nl

prefLabel

Multicenter trial exploring calcineurin inhibitors avoidance in renal transplantation.

@en

Multicenter trial exploring calcineurin inhibitors avoidance in renal transplantation.

@nl

P1433

Q43633987-223B0F1C-0F7C-42AF-9B9F-929807A7205C

P1476

Q43633987-145458A0-C49B-4AE1-94C7-AA2F435BD194

P2093

Q43633987-1A7FEF0E-D345-461E-891F-989CC3CE3287

Q43633987-1B055359-9C3C-42BA-BC73-09DB602B4760

Q43633987-26B637B8-0025-424D-A482-DC714F035E4A

Q43633987-414BF664-F39A-4D15-B74F-33F478148A88

Q43633987-42B5FD4C-3FBD-4F40-8F5C-3DBCDE2AAA1B

Q43633987-81E0BEF9-847A-4C54-BDE9-F1D2E81D9128

Q43633987-83DF8E4F-95C0-4933-BFFB-2E585F7058A4

Q43633987-880345A1-9A59-41A3-9B0F-F00538EA7FF9

Q43633987-BF36985A-8517-4C0A-B004-3A26D4A617B2

Q43633987-C1AD205D-D7C1-4DDA-B06B-AAB06EFBFD72

P304

Q43633987-802270F1-0DAB-4A25-AFD7-A9A2111F6008

P31

Q43633987-920731C3-860E-433B-B908-7AA1B6CC1CD0

P356

Q43633987-F184293F-A68E-4B3B-A606-12ADEFCC0568

P433

Q43633987-4A07C785-E9DF-4163-B71D-2CF481C17177

P478

Q43633987-708DD049-C6E4-4E13-AD06-DB68AFE3C444

P577

Q43633987-A71E8338-8D91-4023-8D43-B8C1625DFE15

P698

Q43633987-3CE5C16D-FBC8-4135-95A8-73C6D756AB47

P356

00007890-200105150-00017

P1433

Transplantation

P1476

Multicenter trial exploring calcineurin inhibitors avoidance in renal transplantation.

@en

P2093

A Khanna

http://www.w3.org/2001/XMLSchema#string

B Nashan

http://www.w3.org/2001/XMLSchema#string

C Brattstrom

http://www.w3.org/2001/XMLSchema#string

D Kuypers

http://www.w3.org/2001/XMLSchema#string

E Ramos

http://www.w3.org/2001/XMLSchema#string

F Stuart

http://www.w3.org/2001/XMLSchema#string

F Vincenti

http://www.w3.org/2001/XMLSchema#string

H Ekberg

http://www.w3.org/2001/XMLSchema#string

J Grinyo

http://www.w3.org/2001/XMLSchema#string

M Navarro

http://www.w3.org/2001/XMLSchema#string

P304

1282-1287

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/00007890-200105150-00017

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

71

http://www.w3.org/2001/XMLSchema#string

P577

2001-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11397963

http://www.w3.org/2001/XMLSchema#string